Filings · News reference

Femasys Files Prospectus Related To The Offer And Resale From Time To Time By The Selling Stockholders Of Up To An Aggregate Of 28,124,997 Shares Of Common Stock

Sep 3, 2026, 9:10 PMBenzinga Newsdesk

https://www.sec.gov/Archives/edgar/data/1339005/000114036126035625/ny20081537x1_s3.htm

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 26, 2026, 1:04 PMBenzinga Newsdesk
Femasys Partners With UNC Health To Introduce Fertility Diagnostics, FemVue And SpermVue, Together With Femaseed Complete Within UNC Health OB/GYN Practice Locations
-- For the first time, OB/GYNs within the UNC Health system will be able to offer women FemVue® fertility evaluation and FemaSeed as a first-line treatment option --ATLANTA, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Femasys
FEMY
BenzingaAug 19, 2026, 5:36 PMVandana Singh
Femasys Secures FDA Pathway for Non-Surgical Contraceptive
FDA clears modular PMA pathway for Femasys' FemBloc, an investigational non-surgical permanent birth control device for women in the US.
FEMY
BenzingaAug 19, 2026, 2:29 PMBenzinga Newsdesk
Femasys shares are trading higher after the company announced that the U.S. Food and Drug Administration has approved the company’s modular premarket approval application pathway for FemBloc.
FEMY